PARTNERRE LTD
PREJFOTCFinancials · Accident & Health Insurance · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.51B | $1.30B | $1.33B | $5.35B | $5.86B |
| Operating income | — | — | — | — | — | — |
| Net income | $246.0M | $310.0M | $234.0M | $360.0M | −$520.3M | $852.6M |
| Total assets | $21.41B | $22.27B | $23.04B | $22.98B | $22.86B | $23.36B |
| Total liabilities | $14.50B | $15.17B | $16.27B | $16.05B | $16.39B | $16.16B |
| Equity | $6.90B | $7.05B | $6.71B | $6.93B | $6.47B | $7.21B |
| EPS (diluted) | $4.76 | $5.61 | $3.53 | $5.24 | $-8.40 | $10.46 |
| Shares out. | 47.4M | 51.6M | 58.4M | 65.4M | 67.6M | 78.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- 16.8%
- Return on equity
- 3.6%
- Return on assets
- 1.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 67.8%
- Debt / equity
- 2.10×
- Book value / share
- $145.56
- Revenue growth (YoY)
- −3.5%
- Net income growth (YoY)
- −20.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Accruals / assets
- −0.3%clean
- Piotroski F-Score
- 6/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 2 good- Revenue declined year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 21,560 | 2.9 | -0.4% |
| Apr 30, 2026 | 21,656 | 1.4 | +1288.2% |
| Apr 15, 2026 | 1,560 | 1.0 | 0.0% |
| Mar 31, 2026 | 1,560 | 1.0 | 0.0% |
| Mar 13, 2026 | 1,560 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Unregistered equity sale · Modified shareholder rights · Amended charter or bylawsMay 3, 2016
- Results of operationsMay 2, 2016
- Director / officer changeApr 20, 2016
- Director / officer change · Other material eventApr 5, 2016
- Other material eventApr 1, 2016
- Director / officer change · Other material eventMar 30, 2016
- Changed auditorMar 24, 2016
- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventMar 18, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.